Related Experiment Video
Updated: Jun 19, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Transcriptional regulation of mouse mast cell protease-2 by interleukin-15
Farhad Mirghomizadeh1, Jörn Bullwinkel, Zane Orinska
1Division of Immunobiology, Department of Immunology and Cell Biology, Research Center Borstel, 23845 Borstel, Germany.
Abstract:
Mast cells (MCs) play a critical role in innate and adaptive immunity through the release of cytokines, chemokines, lipid mediators, biogenic amines, and proteases. We recently showed that the activities of MC proteases are transcriptionally regulated by intracellularly retained interleukin-15 (IL-15), and we provided evidence that this cytokine acts as a specific regulator of mouse mast cell protease-2 (mMCP-2). Here, we show that in wild-type bone marrow-derived mast cells (BMMCs) IL-15 inhibits mMCP-2 transcription indirectly by inducing differential expression and mMCP-2 promoter binding of the bifunctional transcription factors C/EBPbeta and YY1. In wild-type BMMCs, C/EBPbeta expression predominates over YY1 expression, and thus C/EBPbeta preferentially binds to the mMCP-2 promoter. In IL-15-deficient BMMCs, the opposite is found: YY1 expression predominates and binds to the mMCP-2 promoter at the expense of C/EBPbeta. Hypertranscription of the mMCP-2 gene in IL-15-deficient BMMCs is associated with histone acetylation and, intriguingly, with methylation of non-CpG dinucleotides within the MCP-2 promoter. This suggests a novel model of cytokine-controlled protease transcription: non-CpG methylation maintains a chromosomal domain in an "open" configuration that is permissive for gene expression.
Insights
Interleukin-15 (IL-15) regulates mast cell protease-2 (mMCP-2) gene transcription by controlling transcription factors C/EBPbeta and YY1. This cytokine-mediated regulation involves epigenetic mechanisms like non-CpG methylation.
Area of Science:
- Immunology
- Molecular Biology
- Epigenetics
Background:
- Mast cells (MCs) are crucial immune cells releasing various mediators.
- Interleukin-15 (IL-15) was previously identified as a regulator of mast cell protease activity.
- Mouse mast cell protease-2 (mMCP-2) is a key protease regulated by IL-15.
Purpose of the Study:
- To elucidate the mechanism by which IL-15 regulates mMCP-2 transcription.
- To investigate the role of transcription factors C/EBPbeta and YY1 in IL-15-mediated mMCP-2 regulation.
- To explore the epigenetic modifications involved in mMCP-2 gene expression control.
Main Methods:
- Analysis of wild-type and IL-15-deficient bone marrow-derived mast cells (BMMCs).
- Assessment of C/EBPbeta and YY1 expression and promoter binding.
- Chromatin analysis including histone acetylation and non-CpG methylation.
Main Results:
- IL-15 inhibits mMCP-2 transcription in BMMCs by differentially regulating C/EBPbeta and YY1.
- C/EBPbeta predominates in wild-type BMMCs, while YY1 dominates in IL-15-deficient BMMCs, affecting mMCP-2 promoter binding.
- Hypertranscription of mMCP-2 in IL-15-deficient BMMCs correlates with histone acetylation and non-CpG methylation.
Conclusions:
- IL-15 controls mMCP-2 transcription via C/EBPbeta and YY1 balance.
- Non-CpG methylation is implicated in maintaining an open chromatin state for protease gene expression.
- This study proposes a novel model for cytokine-controlled protease gene transcription involving epigenetic regulation.
Related Concept Videos
Master Transcription Regulators
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

